126 related articles for article (PubMed ID: 23337792)
1. Pioglitazone attenuates myocardial ischemia-reperfusion injury via up-regulation of ERK and COX-2.
Wang H; Zhu QW; Ye P; Li ZB; Li Y; Cao ZL; Shen L
Biosci Trends; 2012 Dec; 6(6):325-32. PubMed ID: 23337792
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
Ye Y; Hu Z; Lin Y; Zhang C; Perez-Polo JR
Cardiovasc Res; 2010 Aug; 87(3):535-44. PubMed ID: 20164119
[TBL] [Abstract][Full Text] [Related]
3. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
Ye Y; Lin Y; Atar S; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1158-69. PubMed ID: 16603698
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.
Birnbaum Y; Long B; Qian J; Perez-Polo JR; Ye Y
Basic Res Cardiol; 2011 May; 106(3):431-46. PubMed ID: 21360043
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.
Ye Y; Lin Y; Manickavasagam S; Perez-Polo JR; Tieu BC; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2436-46. PubMed ID: 18931027
[TBL] [Abstract][Full Text] [Related]
6. [Effects of pioglitazone on myocardial peroxisome proliferator-activated receptor gamma co-activator lα expression in rats with myocardial ischemia/reperfusion injury].
Shen L; Wang H; Ye P
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):197-200. PubMed ID: 24589595
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size.
Ye Y; Keyes KT; Zhang CF; Perez-Polo JR; Lin Y; Birnbaum Y
Cardiovasc Drugs Ther; 2010 Apr; 24(2):107-20. PubMed ID: 20379769
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation.
Yin Y; Guan Y; Duan J; Wei G; Zhu Y; Quan W; Guo C; Zhou D; Wang Y; Xi M; Wen A
Eur J Pharmacol; 2013 Jan; 699(1-3):219-26. PubMed ID: 23200898
[TBL] [Abstract][Full Text] [Related]
9. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
10. Salvianolate reduces murine myocardial ischemia and reperfusion injury via ERK1/2 signaling pathways in vivo.
Qi JY; Yu J; Huang DH; Guo LH; Wang L; Huang X; Huang HD; Zhou M; Zhang MZ; Wu J
Chin J Integr Med; 2017 Jan; 23(1):40-47. PubMed ID: 27787719
[TBL] [Abstract][Full Text] [Related]
11. [Effects of pioglitazone on TGFbeta1 expression in ischemia/reperfusion injury myocardium of rats].
Wang H; Ye P; Li Y; Li ZB; Wang L
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Jan; 29(1):1-4. PubMed ID: 23662393
[TBL] [Abstract][Full Text] [Related]
12. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
Cao Z; Ye P; Long C; Chen K; Li X; Wang H
Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
[TBL] [Abstract][Full Text] [Related]
13. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal.
Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH
Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of phosphatidylinositol-3-kinase-protein kinase B and extracellular signal-regulated kinases 1/2 mediate reoxygenation-induced cardioprotection during hypoxia.
Milano G; von Segesser LK; Morel S; Joncic A; Bianciardi P; Vassalli G; Samaja M
Exp Biol Med (Maywood); 2010 Mar; 235(3):401-10. PubMed ID: 20404059
[TBL] [Abstract][Full Text] [Related]
15. A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats.
Kim H; Hwang J; Park S; Nahm SF; Min S; Lim C; Park K; Han S
J Vasc Surg; 2014 Apr; 59(4):1084-9. PubMed ID: 23830318
[TBL] [Abstract][Full Text] [Related]
16. The Protective of Baicalin on Myocardial Ischemia-Reperfusion Injury.
Liu X; Zhang S; Xu C; Sun Y; Sui S; Zhang Z; Luan Y
Curr Pharm Biotechnol; 2020; 21(13):1386-1393. PubMed ID: 32503406
[TBL] [Abstract][Full Text] [Related]
17. Melatonin-Induced Protective Effects on Cardiomyocytes Against Reperfusion Injury Partly Through Modulation of IP3R and SERCA2a Via Activation of ERK1.
Hu S; Zhu P; Zhou H; Zhang Y; Chen Y
Arq Bras Cardiol; 2018 Jan; 110(1):44-51. PubMed ID: 29538523
[TBL] [Abstract][Full Text] [Related]
18. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK.
Baxter GF; Mocanu MM; Brar BK; Latchman DS; Yellon DM
J Cardiovasc Pharmacol; 2001 Dec; 38(6):930-9. PubMed ID: 11707697
[TBL] [Abstract][Full Text] [Related]
20. Antiapoptosis and mitochondrial effect of pioglitazone preconditioning in the ischemic/reperfused heart of rat.
Li J; Lang MJ; Mao XB; Tian L; Feng YB
Cardiovasc Drugs Ther; 2008 Aug; 22(4):283-91. PubMed ID: 18470603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
